EyePoint Pharmaceuticals Inc
EYPT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$26.8M
Close$
$-2.00
744.8% downside
Current Fair Value
744.8% downsideOvervalued by 744.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $26.80 Million |
|---|---|
| Enterprise Value | $-61,288,633.00 |
| Earnings per Share | $-3.17 |
| Beta | 1.85 |
| Outstanding Shares | 86,543,000 |
Return
| Return on Equity | -205.83% |
|---|---|
| Return on Assets | -150.10% |
| Return on Invested Capital | -186.66% |
Valuation & Multiples
| P/E Ratio | -0.1 |
|---|---|
| PEG | -0.16 |
| Price to Sales | - |
| Price to Book Ratio | 0.31 |
| Enterprise Value to Revenue | -22.45 |
| Enterprise Value to EBIT | 0.17 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.39 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 12, 2026
EPS
-$1.07
Est. -$0.93Revenue
$756,000
Est. $231,154Next Earnings Call
Expected Date
March 3, 2027
EPS Estimate
-$0.70
Consensus analyst estimateRevenue Estimate
$279,462
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 3.34, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.
| Put/Call Ratio | 3.3424▲ 144.56% |
|---|---|
| Total Calls | 142,800▼ 90.73% |
| Total Puts | 477,300▼ 83.66% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 11.27%▼ 96.74% |
|---|---|
| Total Invested | $31.93M▼ 97.61% |
| Investors Holding | 53▼ 156.00% |